Neither the FDA, with its charge of protecting safety, nor prospective clients, with their desire for an effective outcome, should be heartened by the outcomes of experimental evaluation of MST.
Read Whole Story
Get top stories and blog posts emailed to me each day. Newsletters may offer personalized content or advertisements. Learn more.